Patents Assigned to LZ Therapeutics, Inc.
  • Methods for extraction and purification of gangliosides
    Patent number: 9394558
    Abstract: Methods for purification and extraction of GM1 ganglioside from cells derived from sheep afflicted with GM1 gangliosidosis or from cells derived from human patients with GM1 gangliosidosis as stable and renewable sources of GM1.
    Type: Grant
    Filed: February 28, 2012
    Date of Patent: July 19, 2016
    Assignee: LZ Therapeutics, Inc.
    Inventors: Jay S. Schneider, Gerri Henwood, Robert Florentine, Christopher Barber
  • Treatment of Glaucoma and Other Retinopathies with Gangliosides
    Publication number: 20140309179
    Abstract: A method of treating or preventing a retinopathy such as glaucoma in a human patient in need thereof comprising administering one or more gangliosides to the patient.
    Type: Application
    Filed: April 17, 2014
    Publication date: October 16, 2014
    Applicant: LZ Therapeutics, Inc.
    Inventors: Jay S. Schneider, Gerri Henwood, Robert Florentine, David W. Anderson